As Per attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sattva Sukun Lifecare's board approved audited FY25 results showing strong growth: total income rose to ₹566.69 lakhs from ₹355.73 lakhs, while profit after tax more than doubled to ₹249.03 lakhs from ₹119.19 lakhs. Two independent directors — Mr. Kishor Anil Kokate and Mrs. Prajakta Anil Gangurde — resigned on the same day citing pre-occupation and personal commitments. Mr. Gaurav Surendra Nair was appointed as an additional non-executive, non-independent director and authorised to sign financial results. The board also finalised terms of a rights issue of up to ₹48 crore (48 crore shares at ₹1 each), with a record date of May 9, 2025 and a ratio of 5 shares for every 2 held, potentially expanding the share count from 19.2 crore to 67.2 crore. The statutory auditor SSRV & Associates issued an unmodified opinion on both standalone and consolidated results.
The financials are positive with profits more than doubling, but the rights issue at a steep 5:2 ratio will triple the share count, leading to significant dilution for existing shareholders. The simultaneous exit of two independent directors on the same day is a governance red flag that investors should monitor.